Osaic Holdings’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.3K | Buy |
4,538
+3,514
| +343% | +$8.78K | ﹤0.01% | 5698 |
|
2025
Q1 | $2.26K | Sell |
1,024
-6,033
| -85% | -$13.3K | ﹤0.01% | 6423 |
|
2024
Q4 | $38.5K | Buy |
7,057
+2,735
| +63% | +$14.9K | ﹤0.01% | 4865 |
|
2024
Q3 | $35.9K | Buy |
4,322
+347
| +9% | +$2.88K | ﹤0.01% | 4950 |
|
2024
Q2 | $28.5K | Buy |
3,975
+119
| +3% | +$852 | ﹤0.01% | 5059 |
|
2024
Q1 | $33.4K | Buy |
3,856
+829
| +27% | +$7.19K | ﹤0.01% | 4996 |
|
2023
Q4 | $19.8K | Sell |
3,027
-2,875
| -49% | -$18.8K | ﹤0.01% | 5487 |
|
2023
Q3 | $59K | Buy |
5,902
+2,558
| +76% | +$25.6K | ﹤0.01% | 4870 |
|
2023
Q2 | $41.6K | Sell |
3,344
-1,374
| -29% | -$17.1K | ﹤0.01% | 5053 |
|
2023
Q1 | $66.1K | Buy |
4,718
+524
| +12% | +$7.34K | ﹤0.01% | 4768 |
|
2022
Q4 | $60.7K | Buy |
4,194
+678
| +19% | +$9.81K | ﹤0.01% | 4787 |
|
2022
Q3 | $90K | Buy |
3,516
+425
| +14% | +$10.9K | ﹤0.01% | 4463 |
|
2022
Q2 | $88K | Sell |
3,091
-23,195
| -88% | -$660K | ﹤0.01% | 4521 |
|
2022
Q1 | $928K | Buy |
26,286
+23,643
| +895% | +$835K | ﹤0.01% | 2646 |
|
2021
Q4 | $111K | Buy |
2,643
+22
| +0.8% | +$924 | ﹤0.01% | 4506 |
|
2021
Q3 | $128K | Sell |
2,621
-29,671
| -92% | -$1.45M | ﹤0.01% | 4303 |
|
2021
Q2 | $1.35M | Buy |
32,292
+28,302
| +709% | +$1.18M | ﹤0.01% | 2073 |
|
2021
Q1 | $142K | Buy |
3,990
+2,097
| +111% | +$74.6K | ﹤0.01% | 4053 |
|
2020
Q4 | $53K | Buy |
+1,893
| New | +$53K | ﹤0.01% | 4502 |
|